About us

Hammersmith Medicines Research (HMR) is a specialist clinical pharmacology unit, with 145 beds in a purpose-designed building, close to an NHS hospital. Since 1993, we’ve provided industry-leading services to pharmaceutical companies for phase I and phase II clinical trials.

In 2001 we set up our own laboratory, and over the last 17 years we’ve built up our range of services so that we now offer a wide variety of specialist analytical techniques.  In January 2009, we moved to new premises with state-of-the-art facilities including:

  • Automated sample handling, sorting, and storage
  • Fast sample delivery to the laboratory from the wards via pneumatic tube transmission
  • Storage at 4°C, –20°C, –70°C, and liquid nitrogen; continuous temperature monitoring
  • Sophisticated laboratory information management system
  • Data export in sponsor’s format
  • Swipecard-control access to all areas
  • Licence and facilities for handling radioactivity

Our vastly increased capacity supports multicentre trials and trials done in other research units.  The central laboratory is gaining a reputation in its own right.

Competitive pricing, fast communication, excellent quality standards, and on-time delivery of results, are key features of our service.  We also offer investigator support specifically tailored for the pharmaceutical industry.

We have a well-established team of experienced Biomedical Scientists with Health Professional Council (HPC) registration, and who participate in the Institute of Biomedical Scientists (IBMS) continuing professional development (CPD) programme.

We’ve maintained laboratory accreditation from 2002, first with the College of American Pathologists (CAP) and since 2018 with UKAS (ISO 17025).

For more information, please see our Services, TechnologyTest menu and Accreditation.